Improving Health in Developing Countries
Michael Kremer and
Rachel Glennerster ()
Chapter Chapter Four in Handbook of Health Economics, 2011, vol. 2, pp 201-315 from Elsevier
We summarize evidence from the growing body of randomized evaluations on health in developing countries from the perspective of the human capital investment model, cost-effectiveness analysis, and behavioral economics. Many cost-effective methods of infectious disease prevention have limited uptake. Contributing factors include externalities from infectious disease prevention, public goods problems, liquidity constraints, and behavioral factors, such as present bias and limited attention. Across a variety of contexts, consumer use of cost-effective products for prevention and non-acute care is highly sensitive to price and convenience. Health education has a mixed record, often working in combination with incentives and functioning through increasing salience rather than delivering information. The quality of health services in many developing countries is very poor, with weak incentives for public sector health workers. Reforms that strengthen incentives show promise but institutional details matter. Programs based on this more nuanced understanding of health decision making can save millions of lives.
Keywords: health; developing countries; randomized experiments; program evaluation (search for similar items in EconPapers)
JEL-codes: C93 D03 I15 O12 (search for similar items in EconPapers)
References: Add references at CitEc
Citations: View citations in EconPapers (3) Track citations by RSS feed
Downloads: (external link)
Full text for ScienceDirect subscribers only
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:eee:heachp:2-201
Access Statistics for this chapter
More chapters in Handbook of Health Economics from Elsevier
Bibliographic data for series maintained by Haili He ().